Back to results
US 2026/0306401 A1Published application
Suspension containing heterocyclidene acetamide derivative
AssigneesSenju Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd.
InventorYuki YAMASHITA
Life of this patent
Estimating the term…
Abstract
The present disclosure provides suspendable ophthalmic solutions with excellent redispersibility. The present disclosure provides an aqueous suspension agent comprising (E)-2-(7-trifluoromethylchroman-4-ylidene)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide or a pharmaceutically acceptable salt or solvate thereof, a cellulosic polymer, and a nonionic surfactant.
Claims11
An aqueous suspension agent comprising:
- (a) (E)-2-(7-trifluoromethylchroman-4-ylidene)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide or a pharmaceutically acceptable salt or solvate thereof;
- (b) a nonionic surfactant;
- (c) a zinc salt or a silver salt;
- and (d) water.
1 more element
Dependencies are inferred from the claim text.